4.6 Article

Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer

Philip Cornford et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines provide evidence-based guidance on the treatment of relapsing, metastatic, and castration-resistant prostate cancer. These guidelines are continuously updated to reflect the latest research findings in the field.

EUROPEAN UROLOGY (2021)

Review Urology & Nephrology

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent

Nicolas Mottet et al.

Summary: The 2020 EAU-EANM-ESTRO-ESUR-SIOG guidelines on screening, diagnosis, and treatment of localized prostate cancer summarize the most recent recommendations for clinical practice, including risk-adapted strategies, medical imaging utilization, biopsy techniques, patient classification, and treatment options. Recommendations include consideration of moderate hypofractionation for intermediate-risk patients and a combination of local treatment with long-term hormonal therapy for cN1 PCa patients.

EUROPEAN UROLOGY (2021)

Review Urology & Nephrology

Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease

Axel Heidenreich et al.

CURRENT OPINION IN UROLOGY (2020)

Review Urology & Nephrology

Local treatment for metastatic prostate cancer: A systematic review

Derya Tilki et al.

INTERNATIONAL JOURNAL OF UROLOGY (2018)

Article Oncology

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases

Axel Heidenreich et al.

EUROPEAN UROLOGY ONCOLOGY (2018)

Article Urology & Nephrology

Local Therapy Improves Survival in Metastatic Prostate Cancer

Sami-Ramzi Leyh-Bannurah et al.

EUROPEAN UROLOGY (2017)

Article Medicine, General & Internal

Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer

Karim Fizazi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

N. D. James et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Christopher J. Sweeney et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Letter Urology & Nephrology

Role of Radical Prostatectomy in Metastatic Prostate Cancer: Data from the Munich Cancer Registry

Christian Gratzke et al.

EUROPEAN UROLOGY (2014)

Article Cell Biology

Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies

Chetan Bettegowda et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

Article Biochemistry & Molecular Biology

Tumor Self-Seeding by Circulating Cancer Cells

Mi-Young Kim et al.

Review Oncology

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond

Rosandra N. Kaplan et al.

CANCER AND METASTASIS REVIEWS (2006)

Review Urology & Nephrology

Metastatic prostate cancer - Does treatment of the primary tumor matter?

Gregory Swanson et al.

JOURNAL OF UROLOGY (2006)